Ελληνικά
Currently, the treatment of teeth with advanced caries and severe pulp inflammation require pulp tissue removal and replacement with an inert material. However, this approach weakens the tooth structure and increases the risk of reinfection. Modern dentistry emphasizes two key principles: tissue preservation and pulp vitality maintenance. Keeping a tooth vital enhances its longevity within the dental arch. Pulp preservation therapies rely on an accurate diagnosis of pulp inflammation severity, which is directly linked to the pulp’s healing potential. However, there is currently no precise tool available to assess the severity of pulp inflammation, posing a major technical challenge to improving the success rate of vital pulp therapies. Identifying relevant biomarkers that reflect both the inflammatory state and the regenerative capacity of the dental pulp is crucial for developing innovative diagnostic tools. Several inflammatory mediators have been investigated, but none have been able to precisely characterize pulp inflammation or its repair potential. Pulp regeneration depends on resident pulp cells, particularly dental pulp mesenchymal stem cells (DP-MSCs), and their microenvironment. In this context, fibrin plays a key role by providing a temporary matrix that is degraded and replaced during tissue repair. Recently, exposed fibrin sites following cleavage have been proposed as potential targets for modulating tissue inflammation. However, little is known about fibrin cleavage in the context of pulp inflammation. We recently analyzed the degradation of a fibrin hydrogel by DP-MSCs using degradomics, a mass spectrometry-based approach specifically designed to identify proteolytic events. This study led to the identification of novel cleavage sites in the fibrinogen alpha chain (FGA). Assuming that the initial cleavage occurs near the C-terminal end of FGA, our preliminary data suggest a sequential and ordered fibrin proteolysis mechanism, progressing from the C-terminal to the N-terminal end, driven by the amino acid sequence of the cleavage site. We hypothesize that these ordered proteolytic events occurring in fibrin correlate with the inflammatory status of the dental pulp and its ability to repair. The PULPITOMIC project aims to use -omics approaches to identify fibrin-derived peptides that could be used as biomarkers to assess pulpitis progression. The main objectives of this project are: (i) to identify by degradomics the fibrin cleavage sites and released fibrin-degradation peptides, in several in vitro and in vivo models of pulpitis, (ii) to select and develop FRET (Fluorescence Resonance Energy Transfer) peptides to monitor fibrinolytic activities and isotopic peptides to quantify the fibrin degradation by targeted proteomics (parallel reaction monitoring, PRM), (iii) to assess pulpitis severity based on fibrin-derived detection tools in vivo in rat and in a bank of human pulpitis. The consortium's expertise in pulp biology, extracellular matrix research, and -omics analysis provides a unique environment for deciphering the proteolytic cleavage events occurring during pulpitis. The PULPITOMIC project will provide proof of concept for developing innovative technologies based on the detection of specific proteolytic activities. These advances will contribute to improving pulpitis diagnosis and adapting treatment and tissue engineering strategies, not only for dental caries but also for other inflamed tissues.
